Evidence map›Paper›PMID 32703153›Full record

ArticleBMC bioinformatics2020

An integrative network-driven pipeline for systematic identification of lncRNA-associated regulatory network motifs in metastatic melanoma.

Nivedita Singh, Martin Eberhardt, Olaf Wolkenhauer, Julio Vera, Shailendra K Gupta

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Are all models wrong?Computational and systems oncology · 2020
    Article
  8. The Atlas of Inflammation Resolution (AIR).Molecular aspects of medicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Nivedita SinghDepartment of Biochemistry, Babu Banarasi Das University, Faizabad Road, Lucknow, Uttar Pradesh, 226028, India.
Martin EberhardtLaboratory of Systems Tumor Immunology, Department of Dermatology, Universitätsklinikum Erlangen and Faculty of Medicine, Friedrich-Alexander University of Erlangen-Nürnberg, Hartmannstr.14, 91052, Erlangen, Germany.
Olaf WolkenhauerDepartment of Systems Biology and Bioinformatics, University of Rostock, 18059, Rostock, Germany.
Julio VeraLaboratory of Systems Tumor Immunology, Department of Dermatology, Universitätsklinikum Erlangen and Faculty of Medicine, Friedrich-Alexander University of Erlangen-Nürnberg, Hartmannstr.14, 91052, Erlangen, Germany.
Shailendra K GuptaDepartment of Systems Biology and Bioinformatics, University of Rostock, 18059, Rostock, Germany. shailendra.gupta@uni-rostock.de.
Universitätsklinikum Erlangen · DEBabu Banarasi Das University · INStellenbosch University · ZAUniversity of Rostock · DE

Funding

Bundesministerium für Bildung und Forschung eBio:MelEVIR [031L0073A]Bundesministerium für Bildung und Forschung eBio:MelEVIR [031L0073B]Bundesministerium für Bildung und Forschung eBio:SysMet [0316171]e:Med MelAutim 01ZX1905Ae:Med MelAutim 01ZX1905BStaedtler Stiftung WW/eh 30/16
6 · The paper itself

Abstract

backgroundMelanoma phenotype and the dynamics underlying its progression are determined by a complex interplay between different types of regulatory molecules. In particular, transcription factors (TFs), microRNAs (miRNAs), and long non-coding RNAs (lncRNAs) interact in layers that coalesce into large molecular interaction networks. Our goal here is to study molecules associated with the cross-talk between various network layers, and their impact on tumor progression.

resultsTo elucidate their contribution to disease, we developed an integrative computational pipeline to construct and analyze a melanoma network focusing on lncRNAs, their miRNA and protein targets, miRNA target genes, and TFs regulating miRNAs. In the network, we identified three-node regulatory loops each composed of lncRNA, miRNA, and TF. To prioritize these motifs for their role in melanoma progression, we integrated patient-derived RNAseq dataset from TCGA (SKCM) melanoma cohort, using a weighted multi-objective function. We investigated the expression profile of the top-ranked motifs and used them to classify patients into metastatic and non-metastatic phenotypes.

conclusionsThe results of this study showed that network motif UCA1/AKT1/hsa-miR-125b-1 has the highest prediction accuracy (ACC = 0.88) for discriminating metastatic and non-metastatic melanoma phenotypes. The observation is also confirmed by the progression-free survival analysis where the patient group characterized by the metastatic-type expression profile of the motif suffers a significant reduction in survival. The finding suggests a prognostic value of network motifs for the classification and treatment of melanoma.

Indexed as

Gene Expression Regulation, NeoplasticGene Regulatory NetworksComputational BiologyHumansMelanomaMicroRNAsMiddle AgedNeoplasm MetastasisPhenotypeRNA, Long NoncodingRNA-SeqTranscription FactorsMicroRNAsRNA, Long NoncodingTranscription FactorsData integrationLncRNAMelanomaMiRNANetwork approachRNA motifSystems biologyTranscription factor

Identifiers

PMID32703153
PMCPMC7376740
OpenAlexW3044115520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.